Introduction
Botanical overview
Rauwolfia serpentina (Sarpagandha) is a perennial evergreen medicinal shrub belonging to the family Apocynaceae. The genus Rauwolfia comprises over 100 species distributed across tropical and subtropical regions of Asia, Africa, Australia, and the Americas. R. serpentina is native to South and Southeast Asia, particularly India, Bangladesh, Sri Lanka, Myanmar, and Malaysia.
Morphological characteristics
The plant typically grows to a height of 60–90 cm and bears simple, lanceolate to elliptic leaves arranged in whorls of three to five. It produces small white to pink flowers and shiny purple-black berries. The most medicinally important part is its elongated tuberous taproot, measuring approximately 30–50 cm in length, which serves as the primary source of bioactive alkaloids.
Traditional and medicinal significance
Rauwolfia serpentina has been widely used in traditional Ayurvedic medicine for centuries, particularly in the management of hypertension, insomnia, anxiety, and neuropsychiatric disorders. Its therapeutic activity is largely attributed to a rich content of indole alkaloids, especially reserpine, which has played a significant role in the development of modern antihypertensive therapy.
Chemical composition of Rauwolfia serpentina
Major phytochemical constituents:
Rauwolfia serpentina contains a wide range of bioactive compounds, including alkaloids, flavonoids, glycosides, phytosterols, tannins, fatty acids, steroids, sugars, and oleoresins.1 Among these, indole alkaloids are the principal pharmacologically active constituents and are primarily responsible for the plant’s therapeutic effects.
More than 50 indole alkaloids have been identified in R. serpentina. These nitrogen-containing compounds are biosynthesized from the amino acid tryptophan and possess significant cardiovascular, neurological, and antihypertensive activities.
Distribution of alkaloids in the plant:
Indole alkaloids are present throughout the plant, including the roots, stems, and leaves; however, the root bark contains the highest concentration. Total alkaloid content generally ranges from 0.7–3.0% of dry weight, depending on species, geographical origin, cultivation conditions, and plant age.
- Important indole alkaloids Several therapeutically important alkaloids have been isolated from R. serpentina, including:
- Reserpine
- Rescinnamine
- Deserpidine
- Ajmaline
- Ajmalicine (Raubasine)
- Serpentine
- Serpentinine
- Yohimbine
- Rauwolfinine
- Sarpagine
- Coryanthine
- Aricine
These alkaloids contribute to the plant’s antihypertensive, antiarrhythmic, sedative, and neuropharmacological properties.
- Reserpine:
Reserpine is the most extensively studied alkaloid of R. serpentina and is largely responsible for its antihypertensive activity. It acts by depleting catecholamines and serotonin from peripheral sympathetic nerve endings, leading to reduced blood pressure and sympathetic tone.
The concentration of reserpine varies considerably among plant samples and generally ranges from 0.03–0.14% of dry weight, with the highest levels found in the roots. Although reserpine is considered a key bioactive marker, other alkaloids such as rescinnamine, deserpidine, canescine, and recanescine also contribute significantly to the pharmacological profile of the plant.
Related Rauwolfia species:
Several species within the Rauwolfia genus, including Rauwolfia vomitoria, Rauwolfia caffra, Rauwolfia tetraphylla, and Rauwolfia heterophylla, contain similar indole alkaloids and have been investigated as alternative sources of bioactive compounds. However, R. serpentina remains the most extensively studied and clinically utilized species.
Pharmacology of Rauwolfia serpentina
Pharmacokinetic properties:
Following oral administration, Reserpine exhibits moderate bioavailability (approximately 50–70%) and is rapidly absorbed. It is widely distributed throughout the body, including the brain, liver, kidneys, spleen, adipose tissue, and peripheral neurons. Reserpine crosses both the blood–brain barrier and placenta and is detectable in breast milk.
The drug undergoes extensive hepatic metabolism, with elimination occurring predominantly through fecal excretion. Its prolonged elimination half-life contributes to sustained pharmacological activity.
Mechanism of action:
- Inhibition of vesicular monoamine transporters
Reserpine exerts its effects by irreversibly binding to vesicular monoamine transporters (VMATs), particularly VMAT2, located in presynaptic neurons. This prevents the storage of monoamine neurotransmitters, including:
- Norepinephrine
- Dopamine
- Serotonin
As neurotransmitter stores become depleted, sympathetic nerve transmission is reduced, resulting in decreased peripheral vascular resistance, reduced cardiac output, and lowering of blood pressure.
- Sympatholytic effects:
Through depletion of catecholamines, reserpine produces2:
- Antihypertensive effects
- Sedative activity
- Reduced sympathetic tone
- Decreased heart rate
These actions account for its historical use in cardiovascular and neuropsychiatric disorders.
Rauwolfia serpentina in hypertension management
Historical clinical evidence:
Rauwolfia serpentina was one of the earliest plant-derived therapies used for hypertension. Clinical studies conducted during the 1940s and 1950s consistently demonstrated significant reductions in both systolic and diastolic blood pressure in patients with essential hypertension.
Treatment with Rauwolfia preparations produced:
- Sustained reductions in blood pressure
- Improvement in associated tachycardia
- Mild sedative effects
- Long-lasting antihypertensive action even after discontinuation
These findings led to widespread clinical use of Rauwolfia-based formulations worldwide.
Clinical efficacy of Reserpine:
Clinical trials evaluating purified reserpine reported substantial reductions in blood pressure among patients with mild-to-severe hypertension. Average reductions of approximately 20–30 mmHg in systolic pressure and 10–20 mmHg in diastolic pressure were commonly observed.
Additional benefits included:
- Reduction in sympathetic overactivity
- Improved sleep quality
- Control of hypertension-associated tachycardia
However, adverse effects such as bradycardia, nasal congestion, sedation, gastrointestinal discomfort, and occasional depressive symptoms limited long-term use.
Evidence from systematic reviews:
Modern evidence from randomized controlled trials indicates that low-dose reserpine remains effective in reducing blood pressure, with efficacy comparable to several first-line antihypertensive agents. Systematic reviews have also suggested potential cardiovascular benefits, including reductions in hypertension-related morbidity and mortality.
Despite demonstrated efficacy, contemporary use is limited because of concerns regarding central nervous system adverse effects and the availability of newer antihypertensive medications with improved safety profiles.
Therapeutic significance
- Role in cardiovascular medicine:
The antihypertensive activity of Rauwolfia serpentina is primarily attributed to reserpine-mediated depletion of catecholamines. Historically, it played a pivotal role in the management of essential hypertension and remains an important example of a successful plant-derived cardiovascular drug.3
- Current perspective:
Although largely replaced by newer antihypertensive agents, Rauwolfia serpentina continues to hold pharmacological significance. Its bioactive alkaloids, particularly reserpine, remain valuable for understanding sympathetic regulation and serve as important leads for cardiovascular drug development.
Conclusion
Rauwolfia serpentina is a medicinal plant of significant pharmacological importance, primarily due to its indole alkaloid reserpine. Through depletion of monoamine neurotransmitters, reserpine exerts potent antihypertensive and sympatholytic effects, making the plant one of the earliest evidence-based herbal therapies for hypertension. Although its clinical use has declined with the advent of newer antihypertensive agents, R. serpentina remains a valuable source of bioactive compounds and continues to hold relevance in cardiovascular research and phytopharmaceutical development.
References:
- Shah SMA, Naqvi SAR, Munir N, Zafar S, Akram M, Nisar J. Antihypertensive and Antihyperlipidemic Activity of Aqueous Methanolic Extract of Rauwolfia Serpentina in Albino Rats. Dose Response. 2020;18(3):1559325820942077. Published 2020 Jul 24. doi:10.1177/1559325820942077. https://pmc.ncbi.nlm.nih.gov/articles/PMC7383702/
- Weir MR. Reserpine: A New Consideration of and Old Drug for Refractory Hypertension. Am J Hypertens. 2020;33(8):708-710. doi:10.1093/ajh/hpaa069. https://pmc.ncbi.nlm.nih.gov/articles/PMC7402223/
- Lobay D. Rauwolfia in the Treatment of Hypertension. Integr Med (Encinitas). 2015;14(3):40-46. https://pmc.ncbi.nlm.nih.gov/articles/PMC4566472/